Quick recap The meeting focused on discussions about kratom regulation, industry challenges, and advocacy efforts. Christopher shared insights from a conversation with an addiction doctor who is interested in learning more about kratom as a leaf versus other products in the market. The group discussed recent news about a theft of $6,740 worth of kratom products, debated the effectiveness of fentanyl test strips, and examined the challenges of proper kratom education being restricted on social media platforms despite allowing other potentially harmful content. They also discussed the need for better regulation of kratom products, particularly addressing concerns about enhanced extracts like 7OH, and explored ways to present fiscal impact data to states considering bans. The conversation touched on personal experiences with medical cannabis and the importance of proper plant medicine usage, while emphasizing the need for proper education and regulation in the kratom industry. Summary Wi-Fi Coverage Discussion Meeting Christopher and Venus discussed Wi-Fi coverage issues at their location. Christopher explained his decision not to expand Wi-Fi to the office area and shared his positive experience with a Wi-Fi extender. They also briefly discussed a news article about a police officer who had stolen something other than Kratom. Kratom Theft and Enforcement Discussion Christopher and Venus discussed a recent theft of $6,740 worth of kratom tablets, with Christopher questioning the reported value given typical retail prices. They also discussed the challenges of drug enforcement and addiction treatment, including the limited effectiveness of fentanyl test strips as people often continue using contaminated drugs. Christopher shared a positive conversation with an addiction doctor who is open to learning about kratom as a leaf and other products in the market. Kratom Regulation and Advocacy Challenges Christopher and Venus discussed the changing landscape of drugs and chemicals, particularly the increased prevalence and abuse of enhanced Kratom products like 7OH. They highlighted the lack of awareness among consumers about different Kratom products and the challenges in providing education due to social media restrictions. Christopher expressed frustration over politicians' disregard for public opinion and evidence during hearings on Kratom regulation, attributing it to political agendas or ignorance. Venus noted that despite challenges, the advocacy efforts are growing louder.

This was such a wonderful day, September 13, 2016 https://youtu.be/UiMdC9rzDIU?si=6e3KELgFRxFHrQ7G

We could have sold 7-OH. We chose safety instead. In this video, Christopher Deaney of Christopher’s Organic Botanicals explains why our company does not sell 7-OH products and why we believe consumers deserve a clear distinction between natural kratom leaf and commercial 7-OH products. Commercial 7-OH is often marketed as “new and improved kratom” or just another kratom extract, but that is misleading. Natural kratom leaf contains only tiny trace amounts of 7-hydroxymitragynine. There is not enough naturally occurring 7-OH in the leaf to create the commercial 7-OH products being sold across the country. That distinction matters. Since 2021, we received calls from people asking about enhanced 7-OH products. By 2024, the calls changed. Consumers were confused, upset, and some felt they had been duped into thinking 7-OH was simply another form of kratom. In nearly 10 years of working with natural kratom, we have never seen that same pattern of issues with plain leaf kratom. Christopher’s Organic Botanicals was built around natural kratom leaf, traditional use, third-party testing, transparency, responsible education, and consumer safety. We fought to keep kratom legal in 2016, including standing in Washington, D.C., sharing kratom tea and personal stories about the plant. This is not about attacking responsible extracts. Some people cannot digest raw leaf powder, and responsibly made extracts or brewed and strained kratom tea can serve a purpose. This is about drawing a clear safety line between natural kratom leaf and commercial 7-OH products being marketed under the kratom name. We are sticking with the leaf. Natural kratom.Traditional use.Testing.Transparency.Consumer safety. That is the line in the sand, and we are not moving it. Learn more: Christopher’s Organic Botanicals https://christophersorganicbotanicals.com Disclaimer: This video is for educational purposes only and is not medical advice. Kratom products are not intended to diagnose, treat, cure, or prevent any disease.

Quick recap This meeting was a discussion among Christopher, Venus, and Twinkle about the current state of kratom legislation and regulations. Christopher shared his recent experience testifying at a Suffolk County hearing in New York, where he faced challenging questions about kratom extracts and safety concerns. The group discussed the differences between natural kratom leaf and synthetic/semi-synthetic extracts, with Christopher explaining that extracts containing compounds like 7-OH and MGM15 are not derived from natural kratom leaf. They also talked about the challenges faced by kratom vendors, including expensive registration requirements in certain states and the ongoing battle to educate policymakers about kratom's safety profile. The conversation touched on personal experiences with kratom products and the evolution of regulations over the years. Meeting Recap Christopher shared updates about his wife's ongoing back pain and MRI experience, noting she remains in pain despite the procedure. Michelle joined late due to another Zoom meeting and mentioned speaking with Governor Kelly's secretary about recent building issues in Kansas. The conversation concluded with Christopher and Michelle discussing their recent experiences participating in public hearings on kratom regulations, during which Christopher was questioned extensively about safety concerns. Home Repairs and Kratom Regulations Christopher checked in with Venus and Twinkle about their well-being, with Venus sharing that she and Eddie are working on house repairs, including installing new windows. Venus expressed gratitude for Eddie's ability to handle the work himself, but noted the lack of financial assistance for home repairs. The conversation shifted to weather conditions and the impact of recent temperature fluctuations on their homes. Christopher and Venus discussed the ongoing challenges with Kratom regulations, agreeing that continued education and advocacy are necessary despite recent developments at the federal level.

Quick recap Christopher and Venus had an extensive discussion about internet connectivity issues and recent regulatory challenges in the kratom industry, particularly focusing on a problematic Nevada Board of Pharmacy meeting where pro kratom testimony was heavily restricted while opponents were given ample time to speak. Christopher expressed frustration with what he viewed as corrupt decision-making processes in multiple states, noting that he would be escalating his concerns to the governor after witnessing biased hearings where positive testimonies were cut short while opponents were allowed extensive time to present their arguments. The conversation also covered technical aspects of internet connectivity solutions, including the use of Wi-Fi extenders and router setups, as well as personal experiences with home fires and safety precautions. Summary Internet Connectivity and Solutions Christopher and Venus discussed their internet connectivity solutions, including the use of Wi-Fi extenders. Christopher shared his experience with a TP-Link extender at work, while Venus mentioned using a Netgear extender. They also talked about backup power systems, with Christopher describing a battery backup system with 4G network capability at his workplace. The conversation briefly touched on the challenges of upgrading to fiber optic internet, with Christopher explaining why his workplace had not yet made the switch due to cost considerations. Nevada Pharmacy Board Kratom Criticism Christopher expressed frustration with the Nevada Board of Pharmacy's meeting, where he claimed the board had predetermined its decision against kratom. He criticized the board for limiting pro-kratom testimony while allowing extensive anti-kratom testimony, and accused them of either corruption or willful ignorance. Christopher stated he would be taking his concerns to the governor and expressed frustration with ongoing challenges in getting states to consider scientific evidence about kratom's benefits.